Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers

Resistance of breast cancer to human epidermal growth factor receptor 2 (HER2) inhibitors involves reprogramming of the kinome through HER2/HER3 signaling via the activation of multiple tyrosine kinases and transcriptional upregulation. The heterogeneity of induced kinases prevents kinase targeting...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Bowen, Mason, Seth, Wilson, Robert C., Hazard, Starr E., Wang, Yubao, Fang, Rong, Wang, Qiwei, Yeh, Elizabeth S., Yang, Meixiang, Roberts, Thomas M., Zhao, Jean J., Wang, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937212/
https://www.ncbi.nlm.nih.gov/pubmed/31462705
http://dx.doi.org/10.1038/s41388-019-0953-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937212/
https://www.ncbi.nlm.nih.gov/pubmed/31462705
http://dx.doi.org/10.1038/s41388-019-0953-9

Ejemplares similares